+91-8668442535

Transdermal Skin Patches Market By Product (Matrix, Drug In Adhesive, Reservoir, Multilaminate), By Application (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Motion Sickness, Neurological Disorder, Cardiovascular Disorder) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Transdermal skin patches are medicated, adhesive patch that is placed on the skin to deliver a specific dose of medicine through the skin and into the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion, thus attaining more steady levels of the drug in the body.

The report titled "Global Transdermal Skin Patches Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall transdermal skin patch market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on product type, application type, and different geographical regions.

The report also includes sections on the competitive profiling of the leading players in the global transdermal skin patches market, attractive investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.

Geographically, the global transdermal skin patch market is studied for the following regional markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • the remainder of MEA

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global transdermal skin patch market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global transdermal skin patch market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global transdermal skin patch market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global transdermal skin patches market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Based on the type of product, the transdermal skin patches market is segmented into:

  • Matrix
  • Drugs in Adhesives
  • Reservoir
  • Vapor

Transdermal patches are medicated adhesive patches that are placed on the skin to deliver a specific dose of medicine through the skin and into the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion, thus attaining more steady levels of the drug in the body. Currently, patches are being marketed that can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.

The transdermal skin patches market is classified into the matrix, drug in the adhesive, reservoir, and vapor products. The matrix segment held the largest share in the overall transdermal skin patch market due to product modifications in terms of controlled release settings. Moreover, the non-toxic and non-antagonistic characteristics of polymer matrix options, which are known to diffuse drugs with controlled precision, would further drive the market in the future.

Based on the type of application, the transdermal skin patches market is segmented into:

  • Pain Relief
  • Nicotine Cessation
  • Hormone replacement therapy
  • Motion Sickness
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Transdermal skin patches offer many advantages over other drug delivery methods like pills, powder, or liquid medication. The most vital benefit of skin patches is that they deliver the drug directly into the bloodstream, bypassing the liver's metabolic activity. The second benefit of using patches is that medication is supplied gradually and constantly rather than in a large, single dose, which is advised in many therapeutic conditions. On the basis of application, the transdermal skin patches are segmented into pain relief, nicotine cessation, hormone replacement therapy, motion sickness, neurological disorders, cardiovascular disorders, and others.

Transdermal patches for pain relief are the major contributing market, as they are preferred over hypodermic injections, which are more painful, generate medical waste, and pose a risk of disease transmission. Improved patient compliance as the treatment is non-invasive, simple, and convenient, and there is greater flexibility in the termination of drugs with the removal of patches.

For the purpose of this study, the global market for transdermal skin patches is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

For the purpose of this study, the global market for transdermal skin patches is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America dominated the global medical foods market, which was followed by Europe. The key market drivers assisting in the growth of transdermal skin patches in North America comprise the rise in research and development in non-invasive methods of treatment for chronic conditions such as pain relief, motion sickness, and other lifestyle-related disorders.

Moreover, in developed countries like the U.S., the U.K., and others in North America and Europe, the adoption rate of non-invasive and novel treatments is higher than in developing nations. However, Asia Pacific has emerged as the fastest-growing region in the transdermal skin patch market due to rising demand for better treatment at an affordable cost in the region. Furthermore, innovation and government funding in the development of cutting-edge technology and healthcare infrastructure would augment the growth of the Asia-Pacific transdermal skin patch market.

Frequently Asked Question:

The Transdermal Skin Patches Market is expected to see significant CAGR growth over the coming years, at 4.2%.

The Transdermal Skin Patches Market is expected to see significant CAGR growth over the coming years, at 4.2%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Abbott Laboratories,ProSolus, Inc.,Medipatch, Inc,,AdhexPharma,Aneva Drug Delivery Systems. are some of the major players in the global market.

 

 

Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58679
Report Format:   PDF
Pages:   120
Rating:    4.7 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support